Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06839469

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Status
Recruiting
Phase
Study type
Observational
Enrollment
106 (estimated)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is (1) to identify disease specific walking-related digital biomarkers of disease severity, and (2) monitor longitudinal changes in natural environments, for extended periods of time, in DMD and SMA.

Detailed description

Spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are genetic disorders that often result in progressive weakness and impaired function. Our recent findings suggest that novel machine-learning (ML)-based abstraction models may map noisy signals from foot-worn sensors (namely, instrumented insoles developed by the project team) into accurate and clinically relevant spatiotemporal and kinetic gait parameters. These gait parameters derived from instrumented insoles may serve as functional biomarkers to detect changes in real world function. All participants will be observed and measured while wearing the instrumented insoles in the lab and in real-life environments.

Conditions

Timeline

Start date
2024-05-01
Primary completion
2027-12-30
Completion
2028-04-01
First posted
2025-02-21
Last updated
2026-04-09

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06839469. Inclusion in this directory is not an endorsement.